Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLCHIVAS: Colchicine for Skin Relapses in IgA Vasculitis
NCT04008316Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Primary completion
- Nov 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in immunoglobulin A vasculitis, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
colchicine
03
Conditions
immunoglobulin A vasculitis
Beyond the preview
Go deeper on NCT04008316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04008316.